Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Atkin

Showing results (31-40 of 378) with videos related to

Pageof 38
Sort By:
Pharmacological Research|October 14, 2018
Effects of curcumin on hypoxia-inducible factor as a new therapeutic targetAfsane Bahrami, Stephen L Atkin, Muhammed Majeed, et al.
Life Sciences|August 4, 2020
miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A reviewMohammed Abdalla, Harshal Deshmukh, Stephen L Atkin, et al.
Journal of Cellular Physiology|December 6, 2017
Dickkopf homolog 3 (DKK3): A candidate for detection and treatment of cancers?Leila Hamzehzadeh, Michele Caraglia, Stephen L Atkin, et al.
Vascular Health and Risk Management|June 23, 2007
Cardiometabolic aspects of polycystic ovarian syndromeLi Wei Cho, Harpal S Randeva, Stephen L Atkin
Journal of Cellular Physiology|October 28, 2018
Narrative review of the effects of antidiabetic drugs on albuminuriaHabib Yaribeygi, Stephen L Atkin, Niki Katsiki, et al.
Oxidative Medicine and Cellular Longevity|March 28, 2020
Molecular Mechanisms Linking Oxidative Stress and Diabetes MellitusHabib Yaribeygi, Thozhukat Sathyapalan, Stephen L Atkin, et al.
Diabetes & Metabolic Syndrome|June 26, 2019
C1q/TNF-related protein-3 and glucose homeostasisHabib Yaribeygi, Farin Rashidfarrokhi, Stephen L Atkin, et al.
Current Opinion in Hematology|September 16, 2017
The regulation and importance of monocyte chemoattractant protein-1Vanessa Bianconi, Amirhossein Sahebkar, Stephen L Atkin, et al.
Nature Reviews. Endocrinology|September 19, 2009
The Diabetes Control and Complications Trial: the gift that keeps givingEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Diabetes Care|June 28, 2006
The effect of glucose variability on the risk of microvascular complications in type 1 diabetesEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Pageof 38

Showing results (31-40 of 378) with videos related to

Sort By:
Pageof 38
Pharmacological Research|October 14, 2018
Effects of curcumin on hypoxia-inducible factor as a new therapeutic targetAfsane Bahrami, Stephen L Atkin, Muhammed Majeed, et al.
Life Sciences|August 4, 2020
miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A reviewMohammed Abdalla, Harshal Deshmukh, Stephen L Atkin, et al.
Journal of Cellular Physiology|December 6, 2017
Dickkopf homolog 3 (DKK3): A candidate for detection and treatment of cancers?Leila Hamzehzadeh, Michele Caraglia, Stephen L Atkin, et al.
Vascular Health and Risk Management|June 23, 2007
Cardiometabolic aspects of polycystic ovarian syndromeLi Wei Cho, Harpal S Randeva, Stephen L Atkin
Journal of Cellular Physiology|October 28, 2018
Narrative review of the effects of antidiabetic drugs on albuminuriaHabib Yaribeygi, Stephen L Atkin, Niki Katsiki, et al.
Oxidative Medicine and Cellular Longevity|March 28, 2020
Molecular Mechanisms Linking Oxidative Stress and Diabetes MellitusHabib Yaribeygi, Thozhukat Sathyapalan, Stephen L Atkin, et al.
Diabetes & Metabolic Syndrome|June 26, 2019
C1q/TNF-related protein-3 and glucose homeostasisHabib Yaribeygi, Farin Rashidfarrokhi, Stephen L Atkin, et al.
Current Opinion in Hematology|September 16, 2017
The regulation and importance of monocyte chemoattractant protein-1Vanessa Bianconi, Amirhossein Sahebkar, Stephen L Atkin, et al.
Nature Reviews. Endocrinology|September 19, 2009
The Diabetes Control and Complications Trial: the gift that keeps givingEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Diabetes Care|June 28, 2006
The effect of glucose variability on the risk of microvascular complications in type 1 diabetesEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Pageof 38